Actinium Pharmaceuticals Inc (ATNM)
1.4700 x 1 1.6000 x 6
Post-market by (Cboe BZX)
1.5200 +0.0300 (+2.01%) 04/02/25 [NYSE Arca]
1.4700 x 1 1.6000 x 6
Post-market 1.5000 -0.0200 (-1.32%) 19:40 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 7,505 | 12,601 | 12,418 | 9,597 | 10,424 |
| Operating Income | -7,505 | -12,601 | -12,418 | -9,597 | -10,343 |
| Other Income | 853 | 1,033 | 1,065 | 927 | 1,019 |
| Pre-tax Income | -6,652 | -11,568 | -11,353 | -8,670 | -9,324 |
| Net Income Continuous | -6,652 | -11,568 | -11,353 | -8,670 | -9,324 |
| Net Income | $-6,652 | $-11,568 | $-11,353 | $-8,670 | $-9,324 |
| EPS Basic Total Ops | -0.21 | -0.37 | -0.38 | -0.31 | -0.33 |
| EPS Basic Continuous Ops | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 |
| EPS Diluted Total Ops | -0.21 | -0.37 | -0.38 | -0.31 | -0.33 |
| EPS Diluted Continuous Ops | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.37 | -0.38 | -0.31 | -0.33 |
| EBITDA(a) | $-7,301 | $-12,399 | $-12,229 | $-9,381 | $-10,225 |